Premiums for Medicare’s prescription drug plans are expected to rise by about 4 percent next year, while Medicare Advantage rates will drop by 4 percent, a new analysis found.
Among the 10 most popular Medicare Part D prescription drug plans, some insurers are raising premiums more than others, according to a new analysis from the consulting firm Avalere Health.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.